{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:03:38Z","timestamp":1762545818447,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004087","name":"Restless Legs Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015190","name":"Houston Methodist Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014275","name":"Parkinson Study Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014427","name":"Dystonia Coalition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017629","name":"Harmony Biosciences LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017629","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.sleep.2025.106634","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T02:52:45Z","timestamp":1749523965000},"page":"106634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pilot study of Pitolisant, a histamine-3 inverse agonist, as adjunct therapy for refractory restless legs syndrome"],"prefix":"10.1016","volume":"133","author":[{"given":"William G.","family":"Ondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2025.106634_bib1","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00063-005-1097-y","article-title":"[Quality of life in restless legs syndrome. Influence of daytime sleepiness and fatigue]","volume":"100","author":"Gerhard","year":"2005","journal-title":"Med Klin"},{"key":"10.1016\/j.sleep.2025.106634_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.sleep.2017.12.003","article-title":"Restless Legs Syndrome \"Patient Odyssey\" survey of disease burden on patient and spouses\/partners","volume":"47","author":"Ondo","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.106634_bib3","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1038\/s41598-017-02981-w","article-title":"Storage of neural histamine and histaminergic neurotransmission is VMAT2 dependent in the zebrafish","volume":"7","author":"Puttonen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.sleep.2025.106634_bib4","first-page":"905","article-title":"Molecular mechanism of histamine clearance by primary human astrocytes","volume":"61","author":"Yoshikawa","year":"2013","journal-title":"GLIA (New York, N Y)"},{"key":"10.1016\/j.sleep.2025.106634_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy183","article-title":"Histamine: neural circuits and new medications","volume":"42","author":"Scammell","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.106634_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz252","article-title":"Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist\/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy","volume":"43","author":"Setnik","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.106634_bib7","article-title":"Pitolisant and other histamine-3 receptor antagonists-an update on therapeutic potentials and clinical prospects","volume":"7","author":"Harwell","year":"2020","journal-title":"Medicines (Basel)."},{"key":"10.1016\/j.sleep.2025.106634_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12031-015-0536-3","article-title":"Interaction between brain histamine and serotonin, norepinephrine, and dopamine systems: in vivo microdialysis and electrophysiology study","volume":"56","author":"Flik","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.sleep.2025.106634_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.106.111039","article-title":"BF2.649 [1-3-[3-(4-Chlorophenyl)propoxy]propylpiperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology","volume":"320","author":"Ligneau","year":"2007","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.sleep.2025.106634_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa220","article-title":"Association of proton pump inhibitor and histamine H2-receptor antagonists with restless legs syndrome","volume":"44","author":"Earley","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.106634_bib11","article-title":"Striatal histamine mechanism in the pathogenesis of restless legs syndrome","volume":"43","author":"Lai","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.106634_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sleep.2016.08.019","article-title":"In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine","volume":"31","author":"Ferre","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.106634_bib13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/jpet.109.158543","article-title":"Histamine potentiates N-methyl-D-aspartate receptors by interacting with an allosteric site distinct from the polyamine binding site","volume":"332","author":"Burban","year":"2010","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.sleep.2025.106634_bib14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.106634_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the international restless legs syndrome study Group rating scale for restless legs syndrome","volume":"4","author":"Walters","year":"2003","journal-title":"Sleep Med"},{"issue":"supple 1","key":"10.1016\/j.sleep.2025.106634_bib16","article-title":"Severity rating of restless legs syndrome: validation of the RLS-6 sclales","volume":"27","author":"Kohen","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.106634_bib17","first-page":"10","article-title":"The Restless Legs Syndrome Quality of Life Instrument (RLS-QLI) is a \"reliable and valid\" tool for assessing the impact of RLS on patients' lives","volume":"1","year":"2004","journal-title":"PharmacoEcon Outcomes News"},{"key":"10.1016\/j.sleep.2025.106634_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2025.106634_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.sleep.2025.106634_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sleep.2025.106634_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.106634_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5664\/jcsm.5396","article-title":"Post hoc analysis of data from two clinical trials evaluating the minimal clinically important change in international restless legs syndrome sum score in patients with restless legs syndrome (Willis-Ekbom disease)","volume":"12","author":"Ondo","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2025.106634_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105522","article-title":"Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a meta-analysis from randomized controlled trials","volume":"167","author":"Wang","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.sleep.2025.106634_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1212\/WNL.0b013e31829a33bd","article-title":"Predictors of placebo response in restless legs syndrome studies","volume":"81","author":"Ondo","year":"2013","journal-title":"Neurology"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725003090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725003090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:00:00Z","timestamp":1762545600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725003090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"alternative-id":["S1389945725003090"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106634","relation":{},"ISSN":["1389-9457"],"issn-type":[{"type":"print","value":"1389-9457"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot study of Pitolisant, a histamine-3 inverse agonist, as adjunct therapy for refractory restless legs syndrome","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106634"}}